Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Premkumar Christadoss

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Current Protocols in Immunology|November 4, 2011
Experimental autoimmune myasthenia gravis in the mouseBo Wu, Elzbieta Goluszko, Ruksana Huda, et al.
Cytokine|August 22, 2006
Immunization of mice with T cell-dependent antigens promotes IL-6 and TNF-alpha production in muscle cellsErdem Tüzün, Jing Li, Nanchaya Wanasen, et al.
Journal of Neuroimmunology|April 19, 2002
Role of IL-5 during primary and secondary immune response to acetylcholine receptorMathilde A Poussin, Elzbieta Goluszko, Juan U Franco, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 productionCaishu Deng, Elzbieta Goluszko, Erdem Tüzün, et al.
Journal of Neuroimmunology|October 24, 2006
Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravisErdem Tüzün, Shamsher S Saini, B Paul Morgan, et al.
Current Protocols in Immunology|February 9, 2013
Experimental autoimmune myasthenia gravis in the mouseBo Wu, Elzbieta Goluszko, Ruksana Huda, et al.
Journal of Neuroimmunology|December 2, 2006
Pros and cons of treating murine myasthenia gravis with anti-C1q antibodyErdem Tüzün, Jing Li, S Shamsher Saini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravisErdem Tüzün, Benjamin G Scott, Elzbieta Goluszko, et al.
Annals of the New York Academy of Sciences|June 24, 2008
Classical complement pathway in experimental autoimmune myasthenia gravis pathogenesisPremkumar Christadoss, Erdem Tüzün, Jing Li, et al.
Journal of Autoimmunity|April 26, 2005
Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatmentErdem Tüzün, Matthew N Meriggioli, Julie Rowin, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Current Protocols in Immunology|November 4, 2011
Experimental autoimmune myasthenia gravis in the mouseBo Wu, Elzbieta Goluszko, Ruksana Huda, et al.
Cytokine|August 22, 2006
Immunization of mice with T cell-dependent antigens promotes IL-6 and TNF-alpha production in muscle cellsErdem Tüzün, Jing Li, Nanchaya Wanasen, et al.
Journal of Neuroimmunology|April 19, 2002
Role of IL-5 during primary and secondary immune response to acetylcholine receptorMathilde A Poussin, Elzbieta Goluszko, Juan U Franco, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2002
Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 productionCaishu Deng, Elzbieta Goluszko, Erdem Tüzün, et al.
Journal of Neuroimmunology|October 24, 2006
Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravisErdem Tüzün, Shamsher S Saini, B Paul Morgan, et al.
Current Protocols in Immunology|February 9, 2013
Experimental autoimmune myasthenia gravis in the mouseBo Wu, Elzbieta Goluszko, Ruksana Huda, et al.
Journal of Neuroimmunology|December 2, 2006
Pros and cons of treating murine myasthenia gravis with anti-C1q antibodyErdem Tüzün, Jing Li, S Shamsher Saini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravisErdem Tüzün, Benjamin G Scott, Elzbieta Goluszko, et al.
Annals of the New York Academy of Sciences|June 24, 2008
Classical complement pathway in experimental autoimmune myasthenia gravis pathogenesisPremkumar Christadoss, Erdem Tüzün, Jing Li, et al.
Journal of Autoimmunity|April 26, 2005
Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatmentErdem Tüzün, Matthew N Meriggioli, Julie Rowin, et al.
Pageof 6